BillionToOne, Inc. (BLLN)

Profile

Full Name

BillionToOne, Inc.

Ticker

NASDAQ: BLLN

Exchange

NASDAQ

Sector

Healthcare

Industry

Diagnostics & Research

Country

United States

IPO

November 6, 2025

Indexes

Not included

Website

https://www.billiontoone.com

Employees

620

Key Details

Price

$91.61(-4.86%)

Market Cap

$4.19B(Mid cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$152.58M(112.72% YoY)

Annual EPS

-$0.93(49.72% YoY)

PE Ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $91.61
    BLLN price is $91.61

    30-Day Relative Volume

    0.75
    BLLN 30-day relative volume is 0.75

    Price Performance

    Price 1-Day Change

    -4.86%
    BLLN price is down -4.86% today

    Price YTD Change

    -
    BLLN price ytd change is unknown

    Price 1-Year Change

    -
    BLLN price 1-year change is unknown

    Price 3-Year Change

    -
    BLLN price 3-year change is unknown

    Price Range

    Price All-Time High

    $138.70
    BLLN price is currently -33.95% below its historical high of $138.70

    Price 3-Year Low

    $88.00
    BLLN price is currently +4.11% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $4.19B
    BLLN market cap is $4.19 billion

    Market Cap 3-Year Change

    -
    BLLN market cap 3-year change is unknown

    Market Cap All-Time High

    $5.91B
    BLLN market cap is currently -29.06% below its historical high of $5.91 billion

    Market Cap Sector Percentile

    85.94%
    BLLN market cap is higher than 85.94% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    BLLN shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    BLLN shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    2.80
    BLLN beta is 2.80

    200-day SMA

    $104.35
    BLLN price is currently -12.20% below its 200-day simple moving average

    50-day SMA

    $104.35
    BLLN price is currently -12.20% below its 50-day simple moving average

    14-Day RSI

    44.51
    BLLN 14-day relative strength index is 44.51

    Volume

    0.75
    BLLN 30-day relative volume is 0.75

    ATR

    $9.43
    BLLN average true range is $9.43

    10-day Historical Volatility

    85.01%
    BLLN 10-day historical volatility is 85.01%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $152.58M
    BLLN annual revenue is $152.58 million

    Revenue Analysts Estimate

    $295.93M
    BLLN annual revenue is currently -48.44% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +112.72%
    BLLN annual revenue is up +112.72% year-on-year

    Revenue Sector Percentile

    71.26%
    BLLN annual revenue is higher than 71.26% of companies in Healthcare sector

    EPS

    EPS

    -$0.93
    BLLN annual earnings per share is -$0.93

    EPS Analysts Estimate

    $0.29
    BLLN annual earnings per share is currently -415.12% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +49.72%
    BLLN annual earnings per share is up +49.72% year-on-year

    EPS Sector Percentile

    57.85%
    BLLN annual earnings per share is higher than 57.85% of companies in Healthcare sector

    Profit

    Gross Profit

    $80.92M
    BLLN annual gross profit is $80.92 million

    Gross Margin

    53.03%
    BLLN annual gross profit margin is 53.03%

    Operating Profit

    -$47.15M
    BLLN annual operating income is -$47.15 million

    Operating Margin

    -30.90%
    BLLN annual operating profit margin is -30.90%

    Net Income

    -$41.57M
    BLLN annual net profit is -$41.57 million

    Net Margin

    -27.24%
    BLLN annual net profit margin is -27.24%

    Expenses

    Total Expenses

    $194.15M
    BLLN annual total expenses is $194.15 million

    Operating Expenses

    $128.06M
    BLLN annual total operating expenses is $128.06 million

    Cost Of Goods Sold

    $71.67M
    BLLN annual cost of goods sold is $71.67 million

    Selling, General & Administrative Expenses

    $91.47M
    BLLN annual SG&A is $91.47 million

    Depreciation & Amortization

    $11.69M
    BLLN annual D&A is $11.69 million

    Interest Expense

    $0.00
    BLLN annual interest expense is $0.00

    Income Tax

    $29.00K
    BLLN annual income tax is $29.00 thousand

    EBIT & EBITDA

    EBIT

    -$47.15M
    BLLN annual earnings before interest & taxes is -$47.15 million

    EBITDA

    -$35.46M
    BLLN annual EBITDA is -$35.46 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $302.06M
    BLLN annual total assets is $302.06 million

    Non Current Assets

    $74.24M
    BLLN annual long term assets is $74.24 million

    Current Assets

    $227.82M
    BLLN annual total current assets is $227.82 million

    Cash and Cash Equivalents

    $191.48M
    BLLN annual cash & cash equivalents is $191.48 million

    Accounts Receivable

    $24.71M
    BLLN annual accounts receivable is $24.71 million

    Inventory

    $8.73M
    BLLN annual inventory is $8.73 million

    Liabilities

    Total Liabilities

    $134.31M
    BLLN annual total liabilities is $134.31 million

    Long Term Liabilities

    $105.92M
    BLLN annual total long term liabilities is $105.92 million

    Current Liabilities

    $28.39M
    BLLN annual current liabilities is $28.39 million

    Accounts Payable

    $4.30M
    BLLN annual accounts payable is $4.30 million

    Debt

    Total Debt

    $109.38M
    BLLN annual total debt is $109.38 million

    Total Debt 1-Year Change

    -25.26%
    BLLN annual total debt is down -25.26% year-on-year

    Long Term Debt

    $103.16M
    BLLN annual long term debt is $103.16 million

    Short Term Debt

    $6.22M
    BLLN annual short term debt is $6.22 million

    Equity & Capital

    Shareholders Equity

    $167.75M
    BLLN annual stockholders equity is $167.75 million

    Book Value

    -$251.66M
    BLLN annual book value is -$251.66 million

    Retained Earnings

    -$282.20M
    BLLN annual retained earnings is -$282.20 million

    Working Capital

    $199.43M
    BLLN annual working capital is $199.43 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$41.38M
    BLLN annual cash from operations is -$41.38 million

    Cash From Operations 1-Year Change

    +22.91%
    BLLN annual cash from operations is up +22.91% year-on-year

    Cash From Investing

    -$5.43M
    BLLN annual cash from investing is -$5.43 million

    Cash From Investing 1-Year Change

    -106.56%
    BLLN annual cash from investing is down -106.56% year-on-year

    Cash From Financing

    $141.02M
    BLLN annual cash from financing is $141.02 million

    Cash From Financing 1-Year Change

    +951.97%
    BLLN annual cash from financing is up +951.97% year-on-year

    CAPEX

    CAPEX

    $5.40M
    BLLN annual capital expenditures is $5.40 million

    CAPEX 1-Year Change

    -12.5%
    BLLN annual capital expenditures is down -12.5% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$46.78M
    BLLN annual free cash flow is -$46.78 million

    Free Cash Flow 1-Year Change

    +21.84%
    BLLN annual free cash flow is up +21.84% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    53.03%
    BLLN annual gross profit margin is 53.03%

    Operating Margin

    -30.90%
    BLLN annual operating profit margin is -30.90%

    Net Margin

    -27.24%
    BLLN annual net profit margin is -27.24%

    ROA & ROE

    ROA

    -16.84%
    BLLN annual return on assets is -16.84%

    ROE

    -41.94%
    BLLN annual return on equity is -41.94%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    BLLN price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    BLLN price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    -17.51
    BLLN price to book ratio is -17.51

    PB Ratio Sector Percentile

    2.96%
    BLLN price to book ratio is higher than 2.96% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    16.50
    BLLN price to sales ratio is 16.50

    PS Ratio Sector Percentile

    77.59%
    BLLN price to sales ratio is higher than 77.59% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $4.11B
    BLLN enterprise value is $4.11 billion

    Enterprise Value Sector Percentile

    85.32%
    BLLN enterprise value is higher than 85.32% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    1793.05
    BLLN EV/EBITDA is 1793.05

    EV/EBITDA Sector Percentile

    100%
    BLLN EV/EBITDA is higher than 100% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    8.03
    BLLN annual current ratio is 8.03

    Quick Ratio

    7.72
    BLLN annual quick ratio is 7.72

    Leverage

    Debt To Equity

    0.65
    BLLN annual debt to equity ratio is 0.65

    Interest Coverage Ratio

    -
    BLLN annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    -
    BLLN piotroski f-score value is unknown

    Altman Z-Score

    18.21
    BLLN altman z-score is 18.21

    Analyst ratings

    Recent major analysts updates

    Dec 10, 25 JP Morgan
    Overweight
    Dec 10, 25 BTIG
    Buy
    Dec 1, 25 Wells Fargo
    Equal-Weight
    Dec 1, 25 Stifel
    Buy
    Dec 1, 25 Piper Sandler
    Overweight
    Dec 1, 25 Jefferies
    Hold
    Dec 1, 25 JP Morgan
    Overweight
    Dec 1, 25 BTIG
    Buy

    Institutional Ownership

    Screeners with BLLN included

    Mid cap stocks
    US stocks
    Stocks with high beta
    Stocks below SMA 200
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High Altman Z score stocks
    • What is the ticker symbol for BillionToOne, Inc.?
    • Does BillionToOne, Inc. pay dividends?
    • What sector is BillionToOne, Inc. in?
    • What industry is BillionToOne, Inc. in?
    • What country is BillionToOne, Inc. based in?
    • When did BillionToOne, Inc. go public?
    • Is BillionToOne, Inc. in the S&P 500?
    • Is BillionToOne, Inc. in the NASDAQ 100?
    • Is BillionToOne, Inc. in the Dow Jones?
    • When does BillionToOne, Inc. report earnings?

    What is the ticker symbol for BillionToOne, Inc.?

    The ticker symbol for BillionToOne, Inc. is NASDAQ:BLLN

    Does BillionToOne, Inc. pay dividends?

    No, BillionToOne, Inc. does not pay dividends

    What sector is BillionToOne, Inc. in?

    BillionToOne, Inc. is in the Healthcare sector

    What industry is BillionToOne, Inc. in?

    BillionToOne, Inc. is in the Diagnostics & Research industry

    What country is BillionToOne, Inc. based in?

    BillionToOne, Inc. is headquartered in United States

    When did BillionToOne, Inc. go public?

    BillionToOne, Inc.'s initial public offering (IPO) was on November 6, 2025

    Is BillionToOne, Inc. in the S&P 500?

    No, BillionToOne, Inc. is not included in the S&P 500 index

    Is BillionToOne, Inc. in the NASDAQ 100?

    No, BillionToOne, Inc. is not included in the NASDAQ 100 index

    Is BillionToOne, Inc. in the Dow Jones?

    No, BillionToOne, Inc. is not included in the Dow Jones index

    When does BillionToOne, Inc. report earnings?

    The date for BillionToOne, Inc.'s next earnings report has not been announced yet
    On this page